Paula Ocaranza, Germán Íñiguez, M. Cecilia Johnson, Fernando Cassorla
{"title":"雄激素和雌激素对HEPG2细胞生长激素敏感性的不同影响","authors":"Paula Ocaranza, Germán Íñiguez, M. Cecilia Johnson, Fernando Cassorla","doi":"10.1016/j.ghir.2021.101390","DOIUrl":null,"url":null,"abstract":"<div><p>Testosterone and estrogen concentrations progressively increase during puberty, and in association with growth hormone (GH), lead to the increase in height velocity known as the pubertal growth spurt. Very limited information is available however, regarding the possible effects of sex steroids over GH cellular sensitivity.</p></div><div><h3>Objective</h3><p>To investigate the effects of different concentrations of testosterone, estradiol and dihydrotestosterone over the GH intracellular signaling pathway.</p></div><div><h3>Methods</h3><p>We evaluated the effects of these sex steroids on the nuclear phosphorylation of STAT5b and <em>IGF-1</em> expression, in HEPG2 human hepatoma cells. In addition, we studied whether Tamoxifen (TAM), can modulate these effects.</p></div><div><h3>Results</h3><p>The highest concentration of T tested (10 ng/mL) co-incubated with a fixed concentration of GH (40 ng/mL) increased nuclear STAT5b phosphorylation compared with GH alone (1.34 ± 0.2 vs 0.6 ± 0.09 AU; *<em>p</em> < 0.05), as well as <em>IGF-1</em> expression (0.6 ± 0.03 vs 0.32 ± 0.05 AU; *p < 0.05). This effect was not observed with lower concentrations of T tested (1 and 5 ng/mL). A similar increase in nuclear STAT5b phosphorylation was observed with the lowest concentration of E<sub>2</sub> tested (20 pg/mL), co-incubated with the same fixed concentration of GH (3.6 ± 0.5 vs 1.28 ± 0.33 AU; *<em>p</em> < 0.05). This effect was also associated with an increase in <em>IGF-1</em> expression (0.73 ± 0.02 vs 0.39 ± 0.04 AU; *<em>p</em> < 0.05). These results were not observed with higher concentrations of E<sub>2</sub> tested (75 and 200 pg/mL). DHT at concentrations of 0.1, 0.25 and 0.5 ng/mL, co-stimulated with GH, did not change cytoplasmic STAT5b phosphorylation, nuclear STAT5b or <em>IGF-1</em> expression. In addition, the co-incubation of TAM with the highest concentration of T tested (10 ng/mL) and GH (40 ng/mL) did not change cytoplasmic, nuclear pSTAT5 levels or <em>IGF-1</em> expression.</p></div><div><h3>Conclusions</h3><p>T and E<sub>2</sub> potentiate the GH signaling pathway in a concentration-dependent fashion. The observation that the non-aromatizable androgen dihydrotestosterone does not stimulate this pathway, and that the effects of T are blocked with TAM, suggests that the effects of T over the GH signaling pathway appear to be mediated by estrogen.</p></div>","PeriodicalId":12803,"journal":{"name":"Growth Hormone & Igf Research","volume":"57 ","pages":"Article 101390"},"PeriodicalIF":1.6000,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ghir.2021.101390","citationCount":"0","resultStr":"{\"title\":\"Differential effects of androgens and estrogens over cellular GH sensitivity in HEPG2 cells\",\"authors\":\"Paula Ocaranza, Germán Íñiguez, M. Cecilia Johnson, Fernando Cassorla\",\"doi\":\"10.1016/j.ghir.2021.101390\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Testosterone and estrogen concentrations progressively increase during puberty, and in association with growth hormone (GH), lead to the increase in height velocity known as the pubertal growth spurt. Very limited information is available however, regarding the possible effects of sex steroids over GH cellular sensitivity.</p></div><div><h3>Objective</h3><p>To investigate the effects of different concentrations of testosterone, estradiol and dihydrotestosterone over the GH intracellular signaling pathway.</p></div><div><h3>Methods</h3><p>We evaluated the effects of these sex steroids on the nuclear phosphorylation of STAT5b and <em>IGF-1</em> expression, in HEPG2 human hepatoma cells. In addition, we studied whether Tamoxifen (TAM), can modulate these effects.</p></div><div><h3>Results</h3><p>The highest concentration of T tested (10 ng/mL) co-incubated with a fixed concentration of GH (40 ng/mL) increased nuclear STAT5b phosphorylation compared with GH alone (1.34 ± 0.2 vs 0.6 ± 0.09 AU; *<em>p</em> < 0.05), as well as <em>IGF-1</em> expression (0.6 ± 0.03 vs 0.32 ± 0.05 AU; *p < 0.05). This effect was not observed with lower concentrations of T tested (1 and 5 ng/mL). A similar increase in nuclear STAT5b phosphorylation was observed with the lowest concentration of E<sub>2</sub> tested (20 pg/mL), co-incubated with the same fixed concentration of GH (3.6 ± 0.5 vs 1.28 ± 0.33 AU; *<em>p</em> < 0.05). This effect was also associated with an increase in <em>IGF-1</em> expression (0.73 ± 0.02 vs 0.39 ± 0.04 AU; *<em>p</em> < 0.05). These results were not observed with higher concentrations of E<sub>2</sub> tested (75 and 200 pg/mL). DHT at concentrations of 0.1, 0.25 and 0.5 ng/mL, co-stimulated with GH, did not change cytoplasmic STAT5b phosphorylation, nuclear STAT5b or <em>IGF-1</em> expression. In addition, the co-incubation of TAM with the highest concentration of T tested (10 ng/mL) and GH (40 ng/mL) did not change cytoplasmic, nuclear pSTAT5 levels or <em>IGF-1</em> expression.</p></div><div><h3>Conclusions</h3><p>T and E<sub>2</sub> potentiate the GH signaling pathway in a concentration-dependent fashion. The observation that the non-aromatizable androgen dihydrotestosterone does not stimulate this pathway, and that the effects of T are blocked with TAM, suggests that the effects of T over the GH signaling pathway appear to be mediated by estrogen.</p></div>\",\"PeriodicalId\":12803,\"journal\":{\"name\":\"Growth Hormone & Igf Research\",\"volume\":\"57 \",\"pages\":\"Article 101390\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2021-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.ghir.2021.101390\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Growth Hormone & Igf Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1096637421000137\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Growth Hormone & Igf Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1096637421000137","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
睾酮和雌激素浓度在青春期逐渐增加,并与生长激素(GH)相关,导致身高速度的增加,即青春期生长突增。然而,关于性类固醇对生长激素细胞敏感性的可能影响的信息非常有限。目的探讨不同浓度睾酮、雌二醇和二氢睾酮对生长激素细胞内信号通路的影响。方法观察这些性类固醇对HEPG2人肝癌细胞STAT5b核磷酸化和IGF-1表达的影响。此外,我们还研究了他莫昔芬(TAM)是否可以调节这些作用。结果最高浓度的T (10 ng/mL)与固定浓度的生长激素(40 ng/mL)共孵育,与生长激素单独孵育相比,细胞核STAT5b磷酸化增加(1.34±0.2 AU vs 0.6±0.09 AU;* p & lt;0.05),以及IGF-1表达(0.6±0.03 vs 0.32±0.05 AU;* p & lt;0.05)。较低浓度的T(1和5 ng/mL)没有观察到这种效应。最低浓度的E2 (20 pg/mL)与相同固定浓度的GH共孵育(3.6±0.5 AU vs 1.28±0.33 AU)时,细胞核STAT5b磷酸化也有类似的增加;* p & lt;0.05)。这种效应还与IGF-1表达的增加有关(0.73±0.02 AU vs 0.39±0.04 AU;* p & lt;0.05)。当E2浓度较高(75和200 pg/mL)时,没有观察到这些结果。与GH共刺激浓度为0.1、0.25和0.5 ng/mL的DHT未改变细胞质STAT5b磷酸化、细胞核STAT5b或IGF-1的表达。此外,TAM与最高浓度T (10 ng/mL)和生长激素(40 ng/mL)共孵育未改变细胞质、细胞核pSTAT5水平或IGF-1表达。结论st和E2以浓度依赖性的方式增强GH信号通路。观察到非芳香化雄激素双氢睾酮不会刺激这一途径,并且T的作用被TAM阻断,这表明T对生长激素信号通路的影响似乎是由雌激素介导的。
Differential effects of androgens and estrogens over cellular GH sensitivity in HEPG2 cells
Testosterone and estrogen concentrations progressively increase during puberty, and in association with growth hormone (GH), lead to the increase in height velocity known as the pubertal growth spurt. Very limited information is available however, regarding the possible effects of sex steroids over GH cellular sensitivity.
Objective
To investigate the effects of different concentrations of testosterone, estradiol and dihydrotestosterone over the GH intracellular signaling pathway.
Methods
We evaluated the effects of these sex steroids on the nuclear phosphorylation of STAT5b and IGF-1 expression, in HEPG2 human hepatoma cells. In addition, we studied whether Tamoxifen (TAM), can modulate these effects.
Results
The highest concentration of T tested (10 ng/mL) co-incubated with a fixed concentration of GH (40 ng/mL) increased nuclear STAT5b phosphorylation compared with GH alone (1.34 ± 0.2 vs 0.6 ± 0.09 AU; *p < 0.05), as well as IGF-1 expression (0.6 ± 0.03 vs 0.32 ± 0.05 AU; *p < 0.05). This effect was not observed with lower concentrations of T tested (1 and 5 ng/mL). A similar increase in nuclear STAT5b phosphorylation was observed with the lowest concentration of E2 tested (20 pg/mL), co-incubated with the same fixed concentration of GH (3.6 ± 0.5 vs 1.28 ± 0.33 AU; *p < 0.05). This effect was also associated with an increase in IGF-1 expression (0.73 ± 0.02 vs 0.39 ± 0.04 AU; *p < 0.05). These results were not observed with higher concentrations of E2 tested (75 and 200 pg/mL). DHT at concentrations of 0.1, 0.25 and 0.5 ng/mL, co-stimulated with GH, did not change cytoplasmic STAT5b phosphorylation, nuclear STAT5b or IGF-1 expression. In addition, the co-incubation of TAM with the highest concentration of T tested (10 ng/mL) and GH (40 ng/mL) did not change cytoplasmic, nuclear pSTAT5 levels or IGF-1 expression.
Conclusions
T and E2 potentiate the GH signaling pathway in a concentration-dependent fashion. The observation that the non-aromatizable androgen dihydrotestosterone does not stimulate this pathway, and that the effects of T are blocked with TAM, suggests that the effects of T over the GH signaling pathway appear to be mediated by estrogen.
期刊介绍:
Growth Hormone & IGF Research is a forum for research on the regulation of growth and metabolism in humans, animals, tissues and cells. It publishes articles on all aspects of growth-promoting and growth-inhibiting hormones and factors, with particular emphasis on insulin-like growth factors (IGFs) and growth hormone. This reflects the increasing importance of growth hormone and IGFs in clinical medicine and in the treatment of diseases.